GPR35 and head and neck squamous cell carcinoma: Further correlation analysis supported the induction of immune cell infiltration and CXCL9, CXCL11, CXCL14, CXCL17, CXCR3, CXCR4, CXCR6, and GPR35 predicted better survival of HNSCC patients.